Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...

Bibliográfalaš dieđut
Váldodahkkit:	Mukhtyar, C, Luqmani, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2007

Geahča maid

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Eular recommendations for vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2007)

Cardiovascular outcomes in ANCA associated vasculitis
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2007)

Cardiovascular involvement in primary systemic vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2009)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Outpatient assessment of systemic vasculitis.
Dahkki: Nataraja, A, et al.
Almmustuhtton: (2007)

Outcome measures in ANCA-associated vasculitis.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

The role of biologic therapies in the management of systemic vasculitis.
Dahkki: Chan, A, et al.
Almmustuhtton: (2006)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2007)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2006)

The vasculitis damage index as a surrogate outcome measure in systemic vasculitis.
Dahkki: McRorie, E, et al.
Almmustuhtton: (1997)

Outcome in systemic vasculitis.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (1998)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2007)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
Dahkki: Walsh, M, et al.
Almmustuhtton: (2011)

Validation of the Birmingham Vasculitis Activity Score (Version 3)
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2009)

Disease assessment in systemic vasculitis
Dahkki: Luqmani, R
Almmustuhtton: (2004)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Outcome in small-vessel systemic vasculitis.
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2006)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
Dahkki: Robson, J, et al.
Almmustuhtton: (2018)

Evaluation of vasculitis disease activity in Europe.
Dahkki: Luqmani, R
Almmustuhtton: (2001)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
Dahkki: Robson JC, et al.
Almmustuhtton: (2018-01-01)

Current status of outcome measure development in vasculitis.
Dahkki: Merkel, P, et al.
Almmustuhtton: (2014)

Validation of a new version of the Birmingbam vasculitis activity score
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Vasculitis: an update.
Dahkki: Luqmani, R
Almmustuhtton: (2014)

Vasculitis: an update.
Dahkki: Luqmani, R
Almmustuhtton: (2014)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
Dahkki: Robson, J, et al.
Almmustuhtton: (2017)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

Discontinuation of therapies in vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

Discontinuation of therapies in vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

Discontinuation of therapies in vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
Dahkki: Luqmani, R
Almmustuhtton: (2012)

A disease-specific patient-reported outcome for ANCA associated vasculitis: scale structure and measurement properties of the AAV- PRO
Dahkki: Robson, J, et al.
Almmustuhtton: (2017)

Pharmacotherapy of vasculitis.
Dahkki: Chan, M, et al.
Almmustuhtton: (2009)

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Dahkki: Robson, J, et al.
Almmustuhtton: (2016)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
Dahkki: Floris, A, et al.
Almmustuhtton: (2016)